Showing results (831-840 of 1,035) with videos related to

Sort By:
Pageof 104
JACC. Cardiovascular Interventions|March 5, 2021
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT IITamim M Nazif, Jeffrey Moses, Rahul Sharma, et al.
Nature Immunology|June 26, 2023
Distinct metabolic requirements regulate B cell activation and germinal center responsesRahul Sharma, Ryan M Smolkin, Priyanka Chowdhury, et al.
Frontiers in Medicine|May 6, 2026
Safety and effectiveness of benralizumab in Indian patients with severe eosinophilic asthma: results from the FAST studyDeepak Talwar, Venkata Nagarjuna Maturu, Priti L Meshram, et al.
Circulation. Cardiovascular Interventions|January 24, 2022
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular DysfunctionTimothy D Henry, C Noel Bairey Merz, Janet Wei, et al.
The Journal of Invasive Cardiology|January 17, 2020
ST-Segment Elevation Myocardial Infarction and Out-of-Hospital Cardiac Arrest: Contemporary Management From the Multicenter START RegistryMeena Zareh, Jeffrey J Rade, Joseph L Thomas, et al.
Circulation Research|May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkRobert D Simari, Carl J Pepine, Jay H Traverse, et al.
JAMA Network Open|November 16, 2023
Mortality in ST-Segment Elevation Myocardial Infarction With Nonobstructive Coronary Arteries and MimickersOdayme Quesada, Mehmet Yildiz, Timothy D Henry, et al.
Scientific Reports|March 8, 2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapyJesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
American Heart Journal|May 28, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW studyThomas J Povsic, Candice Junge, Adel Nada, et al.
Basic Research in Cardiology|November 25, 2016
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trialsAriadna Contreras, Aaron F Orozco, Micheline Resende, et al.
Pageof 104